The Goldman Sachs Group Raises Natera (NASDAQ:NTRA) Price

October 16, 2024. Natera (NASDAQ:NTRA - Free Report) had its price objective lifted by The Goldman Sachs Group from $125.00 to $140.00 in a research report sent to investors on …


Install CouponFollow Chrome Extension   CouponFollow Extension

$125.00
OFF

The Goldman Sachs Group Raises Natera (NASDAQ:NTRA) Price

1 week from now

October 16, 2024. Natera (NASDAQ:NTRA - Free Report) had its price objective lifted by The Goldman Sachs Group from $125.00 to $140.00 in a research report sent to investors on …

marketbeat.com

22%
OFF

Natera, Inc. (NASDAQ:NTRA) Just Reported And Analysts Have …

1 week from now

2 days ago  · Natera, Inc. (NASDAQ:NTRA) just released its quarterly report and things are looking bullish. Revenue crushed expectations at US$440m, beating expectations by 22%. …

yahoo.com

$78.56
OFF

A Glimpse Into The Expert Outlook On Natera Through 9 Analysts

1 week from now

Feb 20, 2024  · Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $78.56, with a high estimate of $87.00 and a low estimate of …

businessinsider.com

$250000000
OFF

Natera, Inc. | Natera Launches Proposed Follow-On Offering

1 week from now

Sep 6, 2023  · Natera, Inc. (Nasdaq: NTRA) (“Natera”), a global leader in cell-free DNA (cfDNA) testing, today announced the launch of a proposed follow-on public offering of $250,000,000 …

natera.com

$250
OFF

Natera Announces Pricing Of $250 Million Follow-On Offering

1 week from now

Sep 7, 2023  · AUSTIN, Texas– (BUSINESS WIRE)– Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced the pricing of its underwritten public …

natera.com

$125.00
OFF

Natera (NASDAQ:NTRA) Shares Gap Up After Better-Than

1 week from now

4 days ago  · The Goldman Sachs Group upped their price target on shares of Natera from $125.00 to $140.00 and gave the stock a "buy" rating in a report on Wednesday, October 16th. …

marketbeat.com

$30
OFF

Newark - Goldman Sachs

1 week from now

2. Makers Village. In four transactions between 2013 and 2015, Goldman Sachs secured $30 million in funding to finance the first two phases of a project to redevelop a 69,000 square foot …

goldmansachs.com

$101
OFF

Natera (NTRA) Stock Price, News & Analysis - MarketBeat

1 week from now

4 days ago  · Natera (NTRA) raised $101 million in an IPO on Thursday, July 2nd 2015. The company issued 6,300,000 shares at $15.00-$17.00 per share. Morgan Stanle, Cowen and …

marketbeat.com

$250
OFF

Natera Announces Pricing Of $250 Million Follow-On Offering

1 week from now

Sep 7, 2023  · Natera, Inc. (Nasdaq: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced the pricing of its underwritten public offering of 4,550,000 shares of its …

natera.com

465%
OFF

Stock Traders Purchase High Volume Of Natera Put Options …

1 week from now

6 days ago  · This is an increase of 465% compared to the typical daily volume of 436 put options. Natera, Inc. (NASDAQ:NTRA - Get Free Report) saw unusually large options trading activity …

marketbeat.com

$135.06
OFF

Natera (NTRA) Stock Forecast And Price Target 2024 - MarketBeat

1 week from now

3 days ago  · According to the 17 analysts' twelve-month price targets for Natera, the average price target is $135.06. The highest price target for NTRA is $175.00, while the lowest price …

marketbeat.com

FAQs about The Goldman Sachs Group Raises Natera (NASDAQ:NTRA) Price Coupon?

Should you buy Natera (NTRA) stock?

The consensus among Wall Street research analysts is that investors should buy NTRA shares. There are currently 1 hold rating, 9 buy ratings, and 1 strong buy rating for the stock. ...

Is Natera a 'comeback' stock after the August 5th lows?

AUSTIN, Texas-- (BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced it will present new data on its personalized and tumor-informed molec... The Investment Committee discuss their comeback stocks following the August 5th lows. ...

How did Natera (NTRA) perform in the last quarter?

Natera, Inc. (NASDAQ:NTRA) reported earnings results on November 8th. The medical research company earned $0.95 EPS for the quarter, surpassing analysts' consensus estimates of $0.96 EPS by $0.01. Natera generated $268.30 million in revenue during the quarter, exceeding analysts' expectations of $259.27 million. ...

Who owns Natera stock?

Top institutional investors of Natera stock include Vanguard Group Inc. (8.64%), JPMorgan Chase & Co. (6.29%), Fred Alger Management LLC (5.79%), Kynam Capital Management LP (2.50%), and Invesco Ltd. (2.11%). Natera's stock is owned by a variety of retail and institutional investors. ...

What are Natera's 1-year target prices?

According to 11 Wall Street analysts, Natera's NTRA stock has 1-year target prices ranging from $48.00 to $87.00. On average, they anticipate the company's stock price to reach $69.67 in the next twelve months, suggesting a possible upside of 11.6% from the current price. ...

What are the share price targets for NTRA?

The share price targets for NTRA range from $48.00 to $87.00. On average, analysts anticipate the company's stock price to reach $69.67 in the next twelve months, suggesting a possible upside of 11.6% from the current price. View NTRA's analysts price targets or top-rated stocks among Wall Street analysts. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension